Timothy S. Phillips, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1000 |
Michael J Schaars, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1000 |
Michael J Monson, MD Surgery Medicare: Medicare Enrolled Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1000 |
Barry J Seidel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1228 |
Barbara Boyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1222 |
Dr. Gavin Mark Ambrosi, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1000 |
Bradley A Bourkland, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Townline Rd, Minocqua, WI 54548 Phone: 715-358-1000 |
News Archive
MAQUET Cardiovascular today announced the launch of its VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System, which utilizes next-generation HEMOPRO cut-and-seal technology to reduce thermal spread and to achieve optimal conduit quality for coronary artery bypass graft (CABG) surgery patients. The minimally invasive VASOVIEW HEMOPRO 2 system is an example of MAQUET Cardiovascular's commitment to EVH, and technologies that promote the highest level of conduit quality.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases ("The Liver Meeting").
Genetic testing holds great promise for the future. Information generated by genetic testing may provide information that leads to new treatments for common diseases such as heart disease and diabetes.
Encapsulating two drugs with different properties into nanovesicles surrounded by antibodies can greatly improve their delivery and efficacy, according to a study led by Xavier Fernández Busquets, director of the joint Nanomalaria unit at the Institute for Bionengineering of Catalonia and the Barcelona Institute for Global Health, an institution supported by "la Caixa"
The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti - holder of the Microbiology and Infectious Diseases Chair at the Collège de France -, have demonstrated that an imbalance in the gut microbiota, also known as "dysbiosis", promotes the onset of colorectal cancer.
› Verified 8 days ago